简体中文
Scientists will know by June or July whether the coronavirus vaccine being developed at the University of Oxford will work, the boss of a pharmaceutical giant has said.
AstraZeneca chief executive Pascal Soriot told Sky News that production was already under way on the potential
COVID-19
vaccine as human trials take place.
The company has partnered with the University of Oxford for the development, manufacture and large-scale distribution of the potential vaccine, and the UK will be "the priority" for its supply.
Speaking to Ian King Live, Mr Soriot added: "The group in Oxford is one of the best in the world. They have moved very quickly.
"By June, July we'll have a first idea already of the efficacy and safety of this vaccine and we'll need to wait a few more months.
"But by June, July we should have a pretty good idea already.
"Production is already ongoing because we need to manufacture enough doses to do the clinical trials as you can imagine.
"We're going to be scaling up so that we are ready by Q4 [October] so we can supply a sufficient number, with the priority going to the UK population."
